Zhengzhou Minzhong Pharmaceutical Co., Ltd., established in 1994, is a professional enterprise that produces and sells semi-synthetic antibiotics raw materials and their formulation products. The factory is located on the Zhengbian Industrial Belt, adjacent to National Highway 107, Beijing-Hong Kong-Macau Expressway, and Longhai Railway. It is only 11 kilometers away from Zhengzhou Xinzheng International Airport, and the road, railway, and air transportation are very convenient.
The company has been committed to the research, production, and sales of the Rifamycin series of products. It always insists on science and technology as the guide and satisfies customer needs as the goal. After many years of dedicated research, it independently developed the “New Process for the Production of Rifapentine”. This process won a national patent and was awarded the second prize for major scientific and technological progress in Henan Province in 2003. In June 2005, the products produced by this patent were jointly recognized as “National Key New Products” by the Ministry of Science and Technology, the Ministry of Commerce, the General Administration of Quality Supervision, and the Environmental Protection Administration, and they received certificates.
In December 2006, the product received the “High-tech Product” certificate issued by the Henan Provincial Science and Technology Department, and was included in the “China High-tech Product Export Catalog”. The company was awarded the “High-tech Enterprise” and has been rated as a national “double-excellent” foreign investment enterprise for many years, and has been recognized as a “Foreign Capital Advanced Technology Enterprise” by the Provincial Department of Commerce.
After more than ten years of innovative development, the company has modern stainless steel pharmaceutical equipment, advanced Hewlett-Packard microelectronic inspection analysis and detection equipment, highly automated GMP standard workshops, an advanced team of pharmaceutical professionals, a strict quality assurance system, and established long-term technical cooperation relationships with Sichuan Antibiotics Research Institute, China Medical Group, Pharmaceutical Research Institute of Zhengzhou University, etc., has strong research and development strength. The company’s products Rifamycin Sodium and Rifapentine passed the GMP certification implemented by the State Drug and Food Administration in 2004. In November 2009, it passed the recertification (Certificate No.: Yu K0098), and Rifapentine passed the European COS certification in December 2008. The company passed the new version of GMP certification in 2015. The products are registered in countries such as India, Ukraine, Russia, Brazil, Mexico, and are exported to Southeast Asia, Europe and other countries and regions, achieving good economic and social benefits.
People from the masses always practice the corporate philosophy of “century-old Minzhong, century-old fine products, green mountains always exist, and green water flows forever”, bear the responsibility and mission of “making good medicines for the people”, strengthen internal management, and pay close attention to product quality. Striving to develop new businesses, and striving to create better economic and social benefits.
The value of the masses: to be the talent needed by enterprises; to produce the products needed by the market; to be the enterprise needed by society!
Company Profile
Zhengzhou Minzhong Pharmaceutical Co., Ltd., established in 1994. We are devoting ourselves to manufacturing and dealing semi synthetic API antibiotic and its pharmaceutical products. Our main products, Rifamycin Sodium and Rifampicin, have the approval number in China, with GMP and the DMF; Our products are exported to many countries and regions. By improving internal management and quality, we are developing new business and working hard for the beautiful future.
Events
- 1994 Set up Minzhong Pharmceutical.
- 2003 won the second prize at the “ward for great technical advancement” and gain China Patent.
- 2004 Rifamycin Sodium and Rifampicin have acquired the GMP certificate.
- 2005 Acquired the national important new products certificate which issued by China Ministry of Science and Technology, China Ministry of Commerce, State Quality & Inspection Bureau of China.
- 2005 State Environmental Protection Administration of China.
- 2006 Won the “high-tech product” certificate, Listed in the China High-tech Exporting Products Directory. Comapany honored “high-tech enterprise”.
- 2008 Rifampicin passed the European COS authentication.
- 2009 Passed the GMP re-authentication.
- 2015 Passed the new GMP.
- 2020 Renewal of production license and obtaining GMP compliance documents
- 2024 Rifamycin sodium obtained WC certificate
- 2025 Kaifeng Minzhong Pharmaceutical Co., Ltd. starting production
